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Abstract
Background: The major cell cycle control acting at the G2 to mitosis transition is triggered in all eukaryotes by
cyclin-dependent kinases (CDKs). In the fission yeast Schizosaccharomyces pombe the activation of the G2/M CDK is
regulated primarily by dephosphorylation of the conserved residue Tyr15 in response to the stress-nutritional
response and cell geometry sensing pathways. To obtain a more complete view of the G2/M control we have
screened systematically for gene deletions that advance cells prematurely into mitosis.
Results: A screen of 82% of fission yeast non-essential genes, comprising approximately 3,000 gene deletion
mutants, identified 18 genes that act negatively at mitotic entry, 7 of which have not been previously described as
cell cycle regulators. Eleven of the 18 genes function through the stress response and cell geometry sensing
pathways, both of which act through CDK Tyr15 phosphorylation, and 4 of the remaining genes regulate the G2/M
transition by inputs from hitherto unknown pathways. Three genes act independently of CDK Tyr15
phosphorylation and define additional uncharacterized molecular control mechanisms.
Conclusions: Despite extensive investigation of the G2/M control, our work has revealed new components of
characterized pathways that regulate CDK Tyr15 phosphorylation and new components of novel mechanisms
controlling mitotic entry.
Background
An important aspect of the eukaryotic cell cycle control
is the co-ordination of cell cycle progression with the
growth of the cell. The investigation of this problem,
extensively studied in the yeasts Saccharomyces cerevi-
siae and Schizosaccharomyces pombe, elucidated the
basic molecular mechanisms of cell cycle control, which
in many aspects are common to all eukaryotes. Genetic
studies in the yeasts revealed that this co-ordination
occurs at both the G1/S and the G2/M transitions, with
G1/S being the major point of control for S. cerevisiae
and G2/M for S. pombe [1,2]. Useful mutants for defin-
ing genes involved in the rate limiting steps of these
transitions are those that advance cells prematurely into
cell division, resulting in cells with a smaller cell size
than normal [3,4]. The first of these mutants in fission
yeast, wee1-50, was defective in a protein kinase that
phosphorylates Tyr15 of the cyclin-dependent kinase
(CDK) Cdc2 [5,6]. Phosphorylation of this conserved
residue inhibits the CDK, and its dephosphorylation by
the phosphatase Cdc25 activates the CDK and triggers
mitosis [7-9]. This posttranslational modification is the
major rate-limiting control of mitotic onset in fission
yeast. Two pathways, the mitogen-activated protein
kinases stress-nutritional response (SR) and the cell geo-
metry sensing (CGS) pathways, regulate Tyr15 phos-
phorylation upstream of Wee1 and Cdc25 [10-15]. The
SR pathway connects the nutrient-responding target of
rapamycin (TOR) pathway to the recruitment of Polo
kinase to the spindle pole body and CDK activation
[15,16]. This pathway is responsible for nutritional mod-
ulation of mitotic entry. The other pathway that con-
trols mitotic entry is formed by the Cdr1 and Cdr2
kinases, which regulate Wee1 activity in response to cell
geometry, and involves a gradient of the protein kinase
Pom1 along the long axis of the cell [13,14,17].
Tyr15 phosphorylation is considered the major regula-
tory mechanism of the G2/M transition in fission yeast.
However, the observation that cells driven by a simpli-
fied cell cycle system lacking this control are still able to
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divide and coordinate cell division with mass increase
suggests the existence of additional regulatory mechan-
isms [18]. The availability of near genome-wide collec-
tions of gene deletions provides an exceptional tool for
systematically identifying components of the pathways
that regulate the G2/M transition.
In this work we have screened the S. pombe gene dele-
tion collection for mutants that prematurely enter into
mitosis. We found 18 genes that function as negative
regulators of mitosis, 7 of which have not been asso-
ciated with cell cycle control before. Further analysis of
these mutants identified putative new elements that reg-
ulate the G2/M transition acting upstream of the SR
and CGS pathways. Additionally, we found genes that
regulate the G2/M transition independently of Tyr15
phosphorylation, defining new rate limiting controls for
mitotic entry. Therefore, our work provides a more
complete view of the regulatory mechanisms acting at
the G2/M transition.
Results and discussion
Systematic screen for small cell size mutants
Given the importance of the G2/M transition for cell
cycle control, we have screened a near genome-wide fis-
sion yeast gene deletion collection [19] to search sys-
tematically for gene deletion mutants that divide
prematurely, with the objectives of characterizing more
comprehensively the components and mechanisms act-
ing in a negative manner at the G2/M control.
We screened 82% of all fission yeast non-essential
genes for mutants dividing prematurely at a small cell
size, but with minimal effects on growth to avoid muta-
tions influencing cell size indirectly [20]. The screening
procedure is summarized in Figure 1a and consisted of
an initial microscopic visual screen followed by length
and width measurements at cell division of candidate
mutants (see Material and methods). Fission yeast cells
grow by linear extension and therefore cell length corre-
lates with cell volume, facilitating the identification of a
relatively subtle size phenotype. We identified 18
mutants that divided at least 1 μ;m shorter than the
wild-type strain, which, under the growth conditions
used, divided at a length of 14.1 μ;m (Figure 1b; Table
1; Additional file 1; Figure S1 in Additional file 2). We
confirmed that cell volume, calculated from length and
width at division, was also reduced in the selected
mutants (Table 1). The smallest mutant found was
wee1Δ, which divided at 7.4 μ;m, around half the cell
length of the control strain. The rest of the mutants
divided with cell lengths of 75 to 93% of the control
strain. In the course of our screen we also observed
mutants with significant heterogeneity in cell size at
division due to the presence of longer cells. Because
these long cells could have arisen from a transient arrest
of the cell cycle or delayed mitosis, they were not stu-
died further.
All mutants grew with doubling times essentially simi-
lar to wild type (Table 1), except for the wee1Δ and
gpa2Δ strains, with doubling times 66% and 40% longer
than the wild-type strain. All mutants showed cell cycle
phase distributions similar to the wild-type strain (Fig-
ure S2 in Additional file 2) except for the wee1Δ
mutant, which had an extended G1 phase as previously
noted [21]. Deletions of five other genes (ypa2,
SPAC227.01c, sft1, cpp1 and Lac1) showed cell sizes
smaller than wild type but were not analyzed any further
because of their sick and slow growing phenotype.
All 18 genes identified are conserved across eukar-
yotes and most can be grouped into four categories
based on their biological functions: (1) regulation of the
G2/M CDK activity and cytokinesis (wee1, clp1, pom1,
nif1, ppa2, pyp1); (2) glucose sensing/cAMP signaling
pathway (pka1, gpa2, git5, git3); (3) mRNA metabolism
(zfs1, ski3, pab2); and (4) chromatin structure (snf5, sol1,
sgf73). Other genes not found in these categories were
SPAC27E2.03c and SPBC19F8.02, with unknown func-
tions. Eleven of the genes identified have been pre-
viously reported to be involved in the G2/M control,
validating our screen. We cannot give an estimate of the
false negative rate of our screen, but it is informative
that all gene deletions reported previously to signifi-
cantly reduce cell size that were present in the set of
mutants we screened were found in our study. Our list
of mutants does not include several other loss-of-func-
tion mutations previously reported to divide at a small
cell size. This was because these other mutant strains
did not divide at a sufficiently small cell volume to
attain the cutoff we used in our growth conditions
(YE4S media, 32°C; Table S2 in Additional file 2). Inter-
estingly, we found seven genes for which the small size
phenotype has not been previously described; ski3, snf5,
sol1, sgf73, pab2, SPBC19F8.02 and SPAC27E2.03c
(Tables 1 and 2).
Comparison of our results with the list of budding
yeast small size mutants identified in [22,23] revealed
only limited overlap confined to gpa2/GPA2 and wee1/
SWE1 (Table S3 in Additional file 2). The SAGA com-
plex involved in chromatin modification was also pre-
sent in both lists but represented by different subunits
(Sgf73 in fission yeast, Ada1 and Spt3 in budding yeast).
The two budding yeast studies differ in the growth con-
ditions used, as Jorgensen et al. [22] scored cell size of
exponentially growing strains while Zhang et al. [23]
determined cell size from cultures grown to saturation.
We specifically examined the cell size phenotype of fis-
sion yeast mutants in ortholog genes of the budding
yeast genes found in [22,23]. Thirty-seven genes were
identified as fission yeast orthologs to the 45 budding
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yeast genes that result in small size when deleted, and
23 were contained in the set of mutant strains screened.
Only four (GPA2/gpa2, SWE1/wee1, SCH9/sck2 and
SLT2/pmk1) genes passed to the liquid screen and
finally only GPA2/gpa2 and SWE1/wee1 showed a signif-
icant small cell size phenotype in both yeasts. Interest-
ingly, none of the genes identified in our study are
directly involved in ribosome biogenesis, which was the
major pathway represented in the small size mutants
found by Jorgensen et al. [22]. This was not because of
a low representation of ‘ribosome biogenesis’ annotated
genes in our set of mutant strains, since approximately
a third of all S. pombe genes annotated to this Gene
Ontology category were present in this set (103 out of
325). The absence of genes involved in ribosome bio-
genesis from our list of small size mutants could be due
to the different strategies used for coordinating cell
division with growth in the two organisms, which in
budding yeast occurs at G1/S while in fission yeast is
usually at G2/M [2]. It is possible that the G1/S control
could be more sensitive to the ribosome biogenesis than
the G2/M control. It is also possible that the small size
phenotype of the budding yeast ribosome biogenesis
gene mutants results as a response of the cell to the
reduction in the growth rate in these mutants rather
than to a direct involvement of these genes in cell mass-
cell cycle coordination.
Most of the identified mutations had only modest
effects on cell size, but we found that combining differ-
ent mutations reduced cell length further. The quintuple
mutant ski3Δ zfs1Δ ppa2Δ snf5Δ clp1Δ divided with a
cell length of 7.2 μ;m, 50% smaller than the wild type
(Figure 1c). The additive interaction between mutations
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Figure 1 Identification of small size mutants. (a) Strategy for the identification of small size mutants in the fission yeast deletion collection.
Microcolonies of 2,969 strains carrying individual deletions of different non-essential genes were visually screened on agar plates of yeast extract
complex medium (YE4S). Candidate strains were grown in YE4S liquid exponential culture and their cell size determined in a secondary visual
screen. Cell length and width of septated cells were measured for each of the selected strains. Gene deletions were confirmed by PCR, and co-
segregation of the phenotype with the gene marker used in the deletion was checked. (b) Cell length at division of the small size mutants
growing exponentially in complex medium. Boxes enclose 50% of the data and lines within the box show median cell length. Whiskers mark
maximum and minimum values that fall within 1.5 standard deviations. Values outside this range are displayed as dots (n = 60 cells). Wt, wild
type. (c) Dividing cells carrying additive combinations of mutations identified in the screen. Cell wall was stained with Blankophor and cell
length at division in microns is indicated under each panel. (d) Length of cells carrying empty vector and overexpressing snf5 or ski3. Left
panels: cell length distribution of the whole population after 20 h of overexpression. Values correspond to the average cell length in microns of
the whole population and standard deviation (n > 125 cells). Right panels: Blankophor-stained cells after 20 h of overexpression.
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different pathways regulating the G2/M transition.
Furthermore, the heterozygous diploid strain ski3+/ski3Δ
zfs1+/zfs1Δ ppa2+/ppa2Δ snf5+/snf5Δ clp1+/clp1Δ was
23% smaller than the control diploid strain (16.6 μ;m
versus 21.4 μ;m), establishing that these genes have a
quantitative effect on the G2/M transition. Additionally,
it has been reported before that an increase in the levels
of Wee1, Pka1, Ppa2, Pyp1, Clp1, Pom1 and Nif1 caused
Table 1 Small size mutants identified in the genome-wide screen in fission yeast












Molecular function Biological process S. cerevisiae
orthologs
wee1 7.4 ± 0.7 9.5 4.1 ± 0.2 80.5 ± 12.6 214 ± 10.4f Protein kinase G2/M transition SWE1






gpa2 10.9 ± 0.9 8.3 4.5 ± 0.3 151.9 ± 18 181 ± 1.3 G protein, a-subunit GPA2
git5 12.9 ± 0.9 7.0 4.5 ± 0.2 179.6 ± 17.3 142 ± 4.9 G protein, b-subunit STE4
git3 12.7 ± 0.8 6.3 4.6 ±0.2 183.9 ± 24.8 145 ± 3.8 G-protein coupled
receptor
GPR1
zfs1 12.3 ± 0.7 5.7 4.1± 0.2 142.7 ± 13.6 140 ± 4.1 RNA binding mRNA degradation CTH1, TIS11
ski3 12.4 ± 0.6 4.8 4.3 ± 0.2 162.2 ± 15.1 135 ± 1.6 SKI complex
component
SKI3
clp1 11.9 ± 0.9 7.6 4.4 ± 0.2 157.7 ± 15.8 138 ± 0.7 Protein phosphatase G2/M transition
cytokinesis
CDC14
pom1 12.3 ± 1.6 13.0 4.5 ± 0.2 174.1 ± 31.1 141 ± 5.3 Protein kinase
nif1 12.5 ± 0.7 5.6 4.3 ± 0.2 159.6 ± 15.2 128 ± 2.3 Protein kinase
inhibitor
G2/M transition DSF2
snf5 12.6 ± 0.7 5.6 4.3 ± 0.2 163.8 ± 15.9 135 ± 1.6 SWI/SNF subunit Chromatin
remodeling
SNF5
sol1 12.9 ± 0.9 7.0 4.3 ± 0.2 162.9 ± 19.6 135 ± 4.4 SWI/SNF subunit SWI1
sgf73 12.7 ± 0.8 6.3 4.2 ± 0.3 157.0 ± 20.9 159 ± 5.1 SAGA subunit Histone
modification
SGF73
pab2 13.1 ± 0.8 6.1 4.3 ± 0.2 165.7 ± 19.3 143 ± 4.7 RNA binding mRNA poly(A) tail
length
SGN1
SPBC19F8.02 12.6 ± 0.6 4.8 4.3 ± 0.2 160.6 ± 14.1 134 ± 1.5 NA NA
SPAC27E2.03c 12.3 ± 0.7 5.7 4.3 ± 0.2 160.3 ± 18.4 157 ± 6.1 GTP binding NA OLA1
ppa2 11.2 ± 1.0 8.9 4.3 ± 0.2 139.7 ± 15.9 136 ± 1.2 Protein phosphatase Signal transduction PPH21, PPH22
pyp1 11.3 ± 0.6 5.3 4.7 ± 0.2 166.2 ± 15.8 143 ± 4.7 Protein phosphatase Stress-response
MAPK cascade
PTP2, PTP3
WT 14.1 ± 0.8 5.7 4.5 ± 0.2 199.4 ± 21.8 129 ± 2.2
Genes in bold are those that have not been previously implicated in cell cycle control. aMean ± standard deviation (SD), n = 60. bCoefficient of variance. cCell
width was measured at the center of the cell. Mean values ± SD (n = 60). dCell volume was estimated assuming S. pombe cell shape as a cylinder topped with
two hemispheres (V = (4/3) × π × (Width/2)3 + π × (Width/2)2 × (Length - Width)). Mean values ± SD (n = 60). eMean ± standard error (n = 3). fThe doubling time
for wee1Δ was longer than that reported for the temperature sensitive wee1-50 mutant at restrictive temperature [3]. This is likely due to the accumulation of
diploid cells and cells with aberrant septa in the deletion mutant. MAPK, mitogen-activated protein kinase; NA, not available.
Table 2 Function of the genes identified on the G2/M control
Through CDK Tyr15 phosphorylation Independent of
Upstream Sty1 Upstream Cdr1 Upstream Sty1, Cdr1 CDK Tyr15 phosphorylation Not determined
wee1 pyp1 pom1 nif1 snf5 ppa2







Analysis of the genetic interaction of the genes identified indicates that most of them act on the G2/M transition through CDK Tyr15 phosphorylation, directly on
the CDK (Wee1), or indirectly, through Cdc25 (Clp1), the stress-nutritional response pathway (Pyp1, Gpa2, Pka1, Git3, Git5, Pab2, SPAC27E2.03c, SPBC19F8.02), the
cell geometry sensing pathway (Pom1) or through both these two latter pathways (Nif1 and Ski3). The role of Snf5, Sol1 and Zfs1 in the G2/M control is
independent of CDK Tyr15 phosphorylation, CDK inhibitor Rum1 and CDK protein levels. Genes in bold are those not previously associated with cell cycle control.
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cell elongation, which is a sign of mitotic delay or arrest
[5,14,24-28]. We tested whether the overexpression of
any of the remaining genes identified in our screen
(SPAC27E2.03c, zfs1, ski3, SPBC19F8.02, snf5, sgf73, sol1
and pab2) also caused cell elongation, and found that
overexpression of ski3 and snf5 significantly increased
cell size (Figure 1d), establishing that they act as gene
dosage-dependent regulators of the G2/M transition.
Novel elements of regulatory pathways of the G2/M
transition
We next investigated if the genes identified encoded
components of the upstream pathways that regulate
the activation of the G2/M CDK. For example, Pom1
and Pyp1 are respectively components of the CGS and
the SR pathways [10,13,14]. We examined genetic
interactions with the regulators Sty1 and Cdr1, which
act at the base of each respective pathway (Figure 2a;
Table S4 in Additional file 2). The plot in Figure 2a
graphically summarizes our results. The sgf73Δ gene
deletion in both cdr1Δ and sty1Δ backgrounds (Table
S4 in Additional file 2), or in a double mutant cdr1Δ
sty1Δ (Figure S3 in Additional file 2), reduced growth
rate dramatically and resulted in cells with cytokinesis
defects, so this gene was excluded from this analysis.
All the remaining double mutants showed cell lengths
similar to or smaller than cdr1Δ and sty1Δ single
mutants. Approximately half the mutations tested (8
out of 17) did not reduce cell length of the sty1Δ
mutant, indicating that the factors encoded by these
genes function upstream of Sty1. This group is made

































































































Figure 2 Small size mutants are defective in the signaling of different G2/M regulatory pathways. (a) Genetic interactions between
identified mutations and the cdr1 and sty1 genes. Horizontal axis represents the ratio of cell length at division of the double mutant of each
identified mutation in combination with sty1Δ over the single sty1Δ mutant. The vertical axis represents the cell length ratio of the double
mutant with cdr1Δ over the single cdr1Δ mutant cell length. Shaded areas indicate genes that showed interaction with either sty1Δ or cdr1Δ. (b)
Distribution of cell length at division and pictures of Blankophor-stained cells of the wild type (wt) and cdr1Δ sty1Δ double mutant strains. Mean
cell length values ± standard deviation (n = 97) are indicated. (c) Cell length at division of triple mutants carrying sty1Δ and cdr1Δ deletions, and
gene deletions that were additive to either sty1Δ or cdr1Δ. P-value was determined by Student’s t-test. (d) Genetic interactions within the group
of mutations that reduce cell size of the cdr1Δ sty1Δ double mutant. In the figure, additive phenotype means that the double is significantly
smaller (P < 0.01) than both single parental strains.
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factors involved in glucose sensing-signaling, Git3,
Git5, Gpa2 and Pka1. A connection between the glu-
cose sensing/cAMP signaling pathway and Sty1 has
previously been noted [29-31] and our work addition-
ally establishes a key role for glucose sensing in the
activation of the CDK. Conversely, all deletions
reduced the size of the cdr1Δ strain except for pom1Δ
as previously shown [13,14], indicating that Pom1 is
the only component of the CGS pathway in our set of
mutants. Interestingly, we also show that Nif1, which
physically interacts with and inhibits Cdr1 [28], also
appears to have a Cdr1-independent role in the G2/M
transition.
The fact that a group of gene deletions (ppa2Δ, sol1Δ,
snf5Δ, zfs1Δ, clp1Δ, ski3Δ, nif1Δ) reduced the cell size
of both the sty1Δ and cdr1Δ strains indicated that these
genes have roles in the G2/M control independently of
these two pathways. To confirm the additive phenotype
to both the sty1 and cdr1 gene deletions, we deleted
these genes in a sty1Δ cdr1Δ strain. The double sty1Δ
cdr1Δ mutant was viable and divided with a larger size
than any of the parental mutants (Figure 2b; Table S5 in
Additional file 2). Neither the ski3 nor nif1 deletion
reduced cell length at division of the cdr1Δ sty1Δ
mutant, suggesting that Ski3 and Nif1 function
upstream of both Cdr1 and Sty1.
The ppa2, sol1, snf5, zfs1 and clp1 gene deletions
reduced cell length at division of the sty1Δ cdr1Δ
mutant (Figure 2c; Table S5 and Figure S4 in Additional
file 2), confirming that their function in the G2/M is
independent of both Sty1 and Cdr1. We investigated the
genetic interactions within this group of genes (Figure
2d; Table S6 in Additional file 2) and found that, in all
cases, mutants carrying pairs of deletions were smaller
than the parental single mutant strains, with the one
exception of the double mutant snf5Δ sol1Δ, which was
similar to the snf5Δ alone. The additive genetic interac-
tions within this group suggest that these genes function
in different pathways. The non-additive snf5Δ sol1Δ
result is consistent with the fact that Snf5 and Sol1 pro-
teins are two subunits of the same complex [32]. Dele-
tion of snf22, which encodes the ATPase subunit of this
complex (not present in the deletions screened), also
showed an advanced mitosis phenotype similar to the
snf5Δ and sol1Δ mutants (cell length at division 12.7 ±
0.6 μ;m), confirming a role of the SWI/SNF complex in
the G2/M control.
This analysis has revealed new components in the G2/
M control that function upstream of Sty1 (Pab2,
SPAC27E2.03c and SPBC19F8.02), has shown that Ski3
and Nif1 function through both Cdr1 and Sty1, and has
identified other elements that function in the G2/M
transition independently of the CGS and SR pathways
(Ppa2, Sol1, Snf5, Zfs1 and Clp1).
Tyr15 phosphorylation-independent regulation of the G2/
M transition
We next investigated how ppa2, sol1, snf5, zfs1 and clp1
act at the G2/M transition. It is known that Clp1 regu-
lates Cdc25 stability and consequently CDK Tyr15 phos-
phorylation [33,34]. We tested if the other genes of this
group also had a role in Tyr15 phosphorylation or in
other aspects of CDK activation. We first analyzed if
CDK protein levels were altered. It is known that co-
overexpression of the mitotic cyclin Cdc13 and CDK
Cdc2 advances cells into mitosis [35]. However, the
levels of Cdc13 and Cdc2 proteins determined both by
western blot (Figure 3a) and by single cell fluorescence-
activated cell sorting (FACS) analysis (Figure 3b) in the
ppa2Δ, snf5Δ and zfs1Δ mutants, and in the double
mutant snf5Δ zfs1Δ were similar to or lower than in the
control strain. Therefore, the mitotic advancement
observed in these mutants cannot be the result of an
increase in CDK protein level. We also tested if the
effects of these genes on the G2/M transition involve
the CDK stoichiometric inhibitor Rum1, which inhibits
the CDK during G1 [36,37]. Mutants carrying the rum1
deletion and the zfs1, ppa2 or snf5 deletions were viable,
and the lengths at division were similar to the corre-
sponding single mutants (Figure 3c). Therefore, the
effects of snf5, zfs1 and ppa2 on the G2/M transition do
not act through Rum1.
Finally, we investigated if these genes alter the phos-
phorylation levels of Cdc2 at residue Tyr15. The levels
of phosphorylated Cdc2 in ppa2Δ, snf5Δ, zfs1Δ and the
double mutant snf5Δ zfs1Δ were similar to those in the
wild-type strain (Figure 3a), suggesting a role in the G2/
M transition independent of Tyr15 phosphorylation reg-
ulation. To further support this observation, we tested if
the effect of these gene deletions was also observed in a
background containing a non-phosphorylatable Cdc2
mutant protein. We used a strain expressing a mutant
Thr14Ala Tyr15Phe Cdc2 kinase (Thr14 is occasionally
phosphorylated [38]) fused to the cyclin Cdc13, which
is well tolerated by the cell [18] contrary to the non-
fused mutant CDK [8]. Cells with this Cdc13-L-Cdc2
fusion protein have a wild-type doubling time, cell
length and cell cycle distribution. In agreement with the
roles of the SR and CGS pathways regulating the G2/M
transition through CDK Tyr15 phosphorylation, the
non-phosphorylatable CDK fusion protein and not the
wild-type fusion protein specifically abolished most of
the effects on mitotic onset of sty1 and cdr1 gene dele-
tions (Figure 3d; Table S7 and Figure S5 in Additional
file 2), establishing that this system can be used for test-
ing if Snf5, Sol1, Ppa2 and Zfs1 act on the G2/M con-
trol through CDK Tyr15 phosphorylation. We deleted
these genes individually in strains with Cdc13-L-Cdc2
or Cdc13-L-(T14A Y15F)Cdc2 fusion proteins.
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Deletions reduced cell length at division of the strain
carrying the Cdc13-L-Cdc2 fusion protein in a similar
way to that observed in the wild-type background (Fig-
ure 3d, upper panel; Table S7 and Figure S6a in Addi-
tional file 2). The deletion of ppa2 in the Cdc13-L-
(T14A Y15F)Cdc2 background rendered cells inviable,
similar to the lethal phenotype of the double mutant
wee1-50 ppa2Δ at restrictive temperature [25]. We mea-
sured cell length at division of the remaining viable
strains and found that cells harboring these deletions
were shorter than the control strain, although the CDK
could not be phosphorylated on Tyr15 (Figure 3d, bot-
tom panel; Table S7 and Figure S6b in Additional file
2). The snf5Δ and sol1Δ deletions were not additive in
the Cdc13-L-(T14A Y15F)Cdc2 background, while
snf5Δ and zfs1Δ were additive, reducing cell length by
23%. These results show that the premature mitosis of
snf5Δ, sol1Δ and zfs1Δ mutants is independent of Tyr15
phosphorylation and establishes that there must be
additional regulatory mechanisms acting at the G2/M
transition.
This systematic screen of more than 80% of fission yeast
non-essential genes has identified a significant proportion
of the genes acting negatively at the G2/M transition. The
18 genes identified are listed in Table 2 together with their
connection to the G2/M control. We found that most of
these genes function through CDK Tyr15 phosphorylation.
Eight of these genes function upstream of sty1, and of
these, three, pab2, SPAC27E2.03c and SPBC19F8.02, are
described here for the first time as negative regulators of
mitotic onset and define new components of the SR path-
way. Only one gene, pom1, acts solely in the CGS pathway.
However, our data indicate that ski3 and nif1 function in
both the SR and CGS pathways, suggesting a cross-talk
between these two pathways previously thought to act
independently.
We found that snf5, sol1, zfs1, ppa2 and clp1 function
independently of both sty1 and cdr1, and that snf5, sol1
and zfs1 act on mitotic onset independently of CDK
Tyr15 phosphorylation. The advanced mitotic phenotype
of their deletions, described for first time for snf5 and



















































































































































Figure 3 Premature cell division of snf5Δ, sol1Δ and zfs1Δ does not result from alteration of CDK protein levels, Rum1 activity or CDK
Tyr15 phosphorylation. (a) Western blot of total cell lysates for phosphorylated-Tyr15 Cdc2, Cdc2, Cdc13 and a-tubulin (Atb2) protein levels in
different small size mutants. (b) Cdc2-YFP (upper panel) or Cdc13-YFP (bottom panel) fluorescent signal in different small size mutants.
Fluorescence signal of >7,000 cells was measured by flow cytometry and plotted as a moving average (window 250 cells) against forward
scattered light. Note the reduced Cdc13-YFP level in the ppa2Δ strain. (c) Cell length at division of small size mutants carrying rum1+ or rum1Δ
gene deletion (n = 60 cells). (d) Size phenotype of gene deletions in a strain carrying the Cdc13-L-Cdc2 (upper panel) or Cdc13-L-(T14A Y15F)
Cdc2 (bottom panel) fusion proteins. Upper panel, n = 60 cells; bottom panel, n = 150 cells. P-value was determined by Student’s t-test. WT, wild
type; YFP, yellow fluorescent protein.
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Rum1 deregulation, indicating that they represent com-
ponents of uncharacterized rate-limiting controls acting
at the G2/M transition. We suggest that the lethality of
ppa2Δ when combined with the Tyr15 mutant CDK
could be due to a role in the G2/M transition also inde-
pendent of Tyr15 phosphorylation. These proteins could
be involved in regulating the dephosphorylation of CDK
substrates given that, in Xenopus laevis eggs, PP2A
phosphatase controls cell cycle progression by counter-
acting the CDK-dependent phosphorylation of mitotic
substrates [39], and in S. cerevisiae, Cdc14 (homolog of
Clp1) dephosphorylates CDK substrates [40]. Alterna-
tively, these proteins could function in some other way
on CDK targets or could inhibit the CDK by unknown
regulatory pathways. However, they would not be
expected to have a role in the assembly of the CDK
complexes given they still exert effects in the presence
of the fusion protein Cdc13-L-Cdc2 (Figure 3d; Table
S7 and Figure S6b in Additional file 2). Alternatively,
these proteins might be involved in the cellular localiza-
tion of the complex and their absence could facilitate
access of the CDK to its substrates. Another possibility
is that these proteins are involved in an as yet uncharac-
terized posttranslational modification of the CDK. The
elucidation of the molecular details of the mechanism of
action of these proteins on the G2/M transition will
require further study.
Conclusions
Much emphasis has been put on Cdc2 Tyr phosphoryla-
tion as the regulatory mechanism that ensures the coor-
dination between cell growth and cell division. However,
the fact that a synthetic CDK lacking the regulatory
phosphorylation site still exhibits a significant degree of
cell size homeostasis [18] argues strongly for the exis-
tence of other layers of regulation. Furthermore, we
have shown here regulation of mitotic onset without
involving CDK Tyr15 phosphorylation. Our work has
identified new components of characterized pathways
and has revealed the existence of new regulatory
mechanisms, and therefore provides a more complete
view of the regulatory network of G2/M control.
Materials and methods
Strains and growth conditions
S. pombe media and methods are described in Moreno et
al. [41]. Strains used are listed in Table S8 in Additional
file 2. Experiments were carried out in yeast extract com-
plex media supplemented with 0.15 mg/ml L-Histidine,
L-Leucine, Adenine and Uridine (YE4S) at 32°C.
Screen for small size mutants
The viable set of a near genome-wide S. pombe haploid
deletion collection [19] was screened for mutants that
divide prematurely with a smaller size than the wild-
type strain. In total, we screened the cell size phenotype
of 2,969 different gene deletions (82% of fission yeast
non-essential genes). Our strategy consisted of an initial
microscopic visual screen of mutants growing on agar
plates of complex media (YE4S) followed by measure-
ments of cell size at division of candidate mutants grow-
ing exponentially in liquid culture. Mutant strains were
arrayed in 96-well plates and 150 μ;l of YE4S per well
was inoculated and incubated at 32°C for >16 h with
shaking. We then inoculated a solid YE4S media plate
using a pin tool and incubated this plate for 12 to 20 h
until small colonies (40 to 60 cells) formed. Each
mutant strain was inoculated in quadruplicate and was
compared with the control strain PN558 (ade6-M210
leu1-32 ura4-D18 h+) growing in the same plate. The
visual screen for cell size phenotypes was carried out
using a Zeiss Axioskop 40 microscope equipped with a
20×/0.4 NA objective and an additional 1.8× magnifica-
tion. From this first screen, we selected 239 different
mutant strains for a second screen in liquid culture, in
which growth conditions were better controlled. Candi-
date mutants were grown in individual flasks containing
15 ml of YE4S media at 32°C, and cell size was screened
when the culture was growing in exponential phase
(0.35 to 0.45 OD595). Cell wall and septum were stained
with Blankophor (1:100,000; MP Biochemicals, Solon,
OH, USA) and cells were observed with a Zeiss Axios-
kop microscope, equipped with a QICam Fast camera
and using a 63×/1.4 NA objective. We selected 68
mutant strains selected at this stage, which were grown
again under the same conditions, and the width and
length of dividing cells measured from pictures. We
selected mutants that divided at least 1 μ;m shorter in
cell length than the control strain. Wide mutants that
showed reduced cell length but wild-type volume were
discarded as these mutants are altered in morphology
rather than in the control of the cell cycle. Finally,
mutants were backcrossed with the wild-type strain to
confirm the co-segregation of the phenotype with the
deletion marker and to remove auxotrophies, and the
specificity of the gene deletion was verified by PCR.
Genes in our set of small size mutants were deleted for
more than 91% of the ORF [19]. Cell size phenotypes of
the new small size mutants identified in our screen have
been annotated in PomBase [42].
Cell length measurements and statistical methods
Cell length and width were measured from pictures of
live Blankophor-stained cells using the PointPicker plug-
in of ImageJ (National Institutes of Health). Cell volume
was estimated from the length and width values by con-
sidering the shape of a fission yeast cell as a cylinder
topped with two hemispheres. Average cell length and
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width values were determined from 60 to 150 cells, and
comparison between strains was done using a two-tailed
unpaired Student’s t-test. In box-and-whisker plots,
boxes are delimited by the first quartile, median and
third quartile, and whiskers mark maximum and mini-
mum values within a range of up to 1.5 standard devia-
tions. Values outside this range are displayed as
individual dots.
Gene deletion and overexpression
Gene deletion was performed as in [43]. Gene targeting
oligos were designed using the tool ‘Gene deletion’ from
the Bähler Lab web site [44]. Overexpression of genes
was done using the multicopy plasmid REP3X under the
thiamine-repressible nmt1 gene promoter [45]. ORFs
were amplified by PCR with specific oligos carrying
restriction enzyme sites for cloning into REP3X. In over-
expression experiments, cells were grown in synthetic
media (EMM) containing 5 μ;g/ml thiamine and expres-
sion of the gene was induced upon thiamine removal by
filtration and incubation in thiamine-free medium for 20
h.
Protein extracts and western blots
Total protein extracts were prepared from 108 cells, col-
lected by centrifugation and resuspended in the same
volume of HB buffer (60 mM b-glycerol phosphate, 15
mM MgCl2, 15 mM EGTA, 1% (v/v) Triton X-100, 150
mM NaCl, 25 mM MOPS-NaOH pH7.2), containing
protease inhibitor (1 mM phenylmethylsulfonyl fluoride
(PMSF and Roche Complete Mini protease inhibitor
cocktail) and phosphatase inhibitors (Roche PhosStop,
Roche, Indianapolis, IN, USA). Cell suspensions were
boiled for 5 minutes, and then transferred to a tube
containing 1.2 ml of glass beads (0.4 mm; Sigma, St
Louis, MO, USA). Cells were disrupted in a FastPrep
cell disruptor (ThermoSavant, Waltham, MA, USA) for
3 × 20 s. HB buffer plus inhibitors (50 μ;l) was added
and the crude extract was recovered and mixed with 5×
sample buffer (20% (v/v) b-mercaptoethanol, 20% (w/v)
SDS, 0.05% (w/v) bromophenol blue, 25% (v/v) glycerol,
300 mM Tris-HCl pH6.8). Finally, extracts were boiled
for 5 minutes and centrifuged at 13,000 rpm for 1 min-
ute. In western blots, Cdc13 was probed with rabbit
polyclonal SP4 antibody [9] (1:3,000); Cdc2 with com-
mercial rabbit polyclonal anti-PSTAIRE (1:250; Santa
Cruz Biotech, Santa Cruz, CA, USA); phoshorylated
Tyr15 Cdc2 with commercial rabbit polyclonal (1:500;
Cell Signaling Technology, Danvers, MA, USA); and
Atb2 with monoclonal TAT1 antibody (1:5,000; gift
from K Gull [46]). Horse radish peroxidase-conjugated
goat anti-mouse or goat anti-rabbit IgG (Pierce-Thermo,
Waltham, MA, USA) were used at a dilution of 1:10,000
as secondary antibodies.
Flow cytometry
DNA content per cell was determined from 104 cells that
were fixed with 70% (v/v) ethanol and then washed with
1 ml 50 mM sodium citrate. Cells were resupended in 0.5
ml 50 mM sodium citrate containing 0.1 mg/ml RNase A
and incubated at 37°C overnight. DNA was stained with
2 μ;g/ml propidium iodide and samples were sonicated
before analysis in a BD FACSCalibur instrument. Single
cell analysis of CDK protein levels was performed from
strains expressing yellow fluorescent protein (YFP)-
tagged Cdc13 or Cdc2 proteins under their native pro-
moters. Cells were grown in YE4S at 32°C and 1 ml of
culture at 0.2 OD595 (approximately 4 × 10
6 cells) was
fixed with 1% (w/v) formaldehyde for 15 minutes; then
cells were washed and resuspended in 1 ml phosphate-
buffered saline. Cells were briefly sonicated prior to mea-
suring fluorescence signal in a FACSCalibur instrument
(BD Biosciences, San Jose, CA, USA) equipped with a
488 nm excitation laser and a 530 nm bandpass filter.
Autofluorescence from a non-YFP tagged strain was sub-
tracted from the YFP fluorescent signal.
Additional material
Additional file 1: Table S1 - strains analyzed and selected in every
step of the cell size screen.
Additional file 2: Supplementary Figures S1 to S6 and Tables S2 to
S8. Figures S1 and S4 to S6: histograms of cell length at division of
different size mutants. Figure S2: cell cycle distributions of the small cell
size mutants identified. Figure S3: photomicrographs showing the
cytokinetic defects of the sgf73Δ sty1Δ cdr1Δ triple mutant. Table S2: loss-
of-function mutations reported previously to decrease cell length at
division in fission yeast. Table S3: comparison of mutants obtained in this
study with S. cerevisiae small size mutants. Tables S4 to S7: cell length
measurements of size mutants. Table S8: yeast strains used in this study.
Abbreviations
CDK: cyclin-dependent kinase; CGS: cell geometry sensing; ORF: open
reading frame; PCR: polymerase chain reaction; SR: stress-nutritional
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